Serum BNP, PTX3, and VEGF levels were of clinical value in the diagnosis of APE‐PAH patients, and serum BNP, PTX3, and VEGF levels were positively correlated with the severity of PAH and could be used as predictors of the severity of PAH. This evidence concerns the gene VEGFA and apparent mineralocorticoid excess.